GRANTPLAN®

Fast, accurate, efficient budgeting

Overcome the complexity of intricate protocols, large enrollment requirements, global site networks and delivery demands. Build better study budgets while reducing costs and improving start-up times – accurately and compliantly.

Market leader for a reason

GrantPlan® simplifies the budgeting process, enabling life sciences companies and CROs to more efficiently, accurately and confidently build and adjust realistic clinical trial budgets and better negotiate investigator grants globally across all study phases and therapeutic areas.

Video
IQVIA GrantPlan Overview

Precision budgeting saves time, money, and increases compliance

Combines most robust data sources across the industry encompassing 5,400+ indications and >100 countries

Make more strategic, informed allocation decisions using latest data from 82K+ final budgets negotiated over last 2 years

Full visibility of previous agreements with sites in prior negotiations, compared to industry benchmarks to make necessary adjustments

Uses FMV line items for more accurate budgeting and greater cost savings; exhausts all data insights prior to pursuing higher cost options

Out-of-box deployment within days; built-in on-demand learning modules; live customer success reps available

GrantPlan
Investigator-Initiated Study (GPI) Tools

While investigator-initiated studies (IIS) have very specific needs, frequently they are not well met. GPI is the only tool built specifically for IIS. It allows users to forecast and evaluate FMV to assess and determine IIS budgets.

  • Includes additional sections and line items accounting for FTE and per hour personnel fees.
  • Codes broken down by specialty and number of years’ experience using in-application calculations.
  • Can enter percent allocation and duration for each FTE and system calculates appropriate budget.

Better inform and defend your decisions with the most up-to-date data available

Sponsors can run budgets through GrantPlan for evidence-based knowledge of what they should expect to see from CROs. Improves transparency and governance.

Benchmarks are continuously expanded with blinded user data at the completion of each study. Data is refreshed quarterly.

Actuals come from at least 3 companies and at least 5 data points no more than 2 years old.

For Price List, where actual data is insufficient, proprietary algorithms substitute benchmark costs which are updated annually. The client never sees a 0 in a line item. Supporting information is provided.

Highlights charges already covered by patient insurance to avoid duplicate billing and save costs.

Solutions you may be interested in

Contact Us